OHSU
Return to Listing

3 result(s) for Gastrointestinal stromal tumor (GIST)

PI Name Protocol # Title
Michael Heinrich IRB00007264 Phase II Study of crenolanib (CP-868,596), a Selective and Potent Inhibitor of PDGFR, for the Treatment of Patients with Advanced Gastrointestinal Stromal Tumors with the D842-related mutations or deletions, including the D842V Mutation in the PDGFRA Gene
Michael Heinrich IRB00008776 An Open-Label Expanded Access Program of Regorafenib in Patients with Gastrointestinal Stromal Tumors (GIST) After Disease Progression On or Intolerance to Imatinib and Sunitinib
Michael Heinrich IRB00008932 SARC022: A Phase 2 Study of OSI-906 in Pediatric and Adult Wild Type Gastrointestinal Stromal Tumors
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080
 

You may qualify for additional trials within our Phase 1 Program